This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Wyeth Pharmaceutical Co. Ltd
Wyeth Pharmaceutical Co. Ltd., a prominent player in the global pharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in the early 20th century, the company has achieved significant milestones, establishing itself as a leader in innovative healthcare solutions. Specialising in a diverse range of therapeutic areas, Wyeth focuses on biologics, vaccines, and prescription medications, with a commitment to improving patient outcomes. Its core products are distinguished by their advanced formulations and rigorous research and development processes, ensuring high efficacy and safety standards. With a strong market position, Wyeth Pharmaceutical Co. Ltd. is recognised for its contributions to public health and has garnered numerous accolades for its pioneering work in pharmaceuticals. The company continues to drive advancements in medicine, reinforcing its reputation as a trusted name in the healthcare sector.
DitchCarbon Score
How does Wyeth Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wyeth Pharmaceutical Co. Ltd's score of 79 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Wyeth Pharmaceutical Co. Ltd, headquartered in China (CN), currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Haleon plc, which means that any climate commitments or emissions data may be inherited from its parent organisation. As of now, Wyeth Pharmaceutical has not publicly outlined any specific reduction targets or initiatives. However, it is important to note that the climate commitments and performance metrics may be influenced by Haleon plc's sustainability strategies, which include various initiatives aimed at reducing carbon emissions across their operations. Given the absence of direct emissions data, stakeholders should look to Haleon plc for insights into the broader climate strategies and performance metrics that may impact Wyeth Pharmaceutical's environmental footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 59,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wyeth Pharmaceutical Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
